Skip to main content

Table 2 Malaria and adverse birth outcomes during pregnancy and at delivery (n = 400)

From: Pharmacokinetics of piperaquine and its association with intermittent malaria preventive therapy outcomes during pregnancy

Outcomes

Frequency

Parasitemia during pregnancy

Symptomatic malaria during pregnancy+ (95% CI)

2 (0.3 to 6)

Parasitemia during ANC+ (95% CI)

33 (21 to 41)

Parasitemia at delivery

Histopathological placental malaria (active & past) % (n)

3.0 (12)

Histopathological placental malaria [parasites] (active only) %, (n)

1.5 (6)

Histopathological placental malaria [pigments] (past only) %, (n)

1.5 (6)

*Any parasitemia at delivery % (n)

9.8 (39)

Any adverse birth outcomes % (n)

22.5 (90)

  1. +Incidence per 100 person-year at risk; *Any malaria at delivery detected from placental tissue by histopathology, from a maternal, cord, or placental blood by RDT, microscopy, or PCR; CI = 95% Confidence interval